Chi Jin

Suqian, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Transcription Factor HOXC11 Drives Colorectal Cancer Progression and Metastasis via CAMK2A-Dependent CXCL5 Upregulation.

Transcription Factor HOXC11 Drives Colorectal Cancer Progression and Metastasis via CAMK2A-Dependent CXCL5 Upregulation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 28, 2026

Histone Lactylation in Cancer-Associated Fibroblasts Induces Extracellular Matrix Remodeling and Immunosuppression to Promote Colorectal Cancer Progression.

Histone Lactylation in Cancer-Associated Fibroblasts Induces Extracellular Matrix Remodeling and Immunosuppression to Promote Colorectal Cancer Progression.

Journal: Cancer research
Published: November 17, 2025

REEP6 promotes colorectal cancer glycolysis and tumorigenesis through PRMT5-mediated PGAM1 arginine methylation.

REEP6 promotes colorectal cancer glycolysis and tumorigenesis through PRMT5-mediated PGAM1 arginine methylation.

Journal: Acta pharmaceutica Sinica. B
Published: March 13, 2025

FBXO44 Regulates FOXP1 Degradation Through AURKA-Dependent Phosphorylation to Promote Colorectal Cancer Progression.

FBXO44 Regulates FOXP1 Degradation Through AURKA-Dependent Phosphorylation to Promote Colorectal Cancer Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 21, 2024

CircSATB1 Promotes Colorectal Cancer Liver Metastasis through Facilitating FKBP8 Degradation via RNF25-Mediated Ubiquitination.

CircSATB1 Promotes Colorectal Cancer Liver Metastasis through Facilitating FKBP8 Degradation via RNF25-Mediated Ubiquitination.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 22, 2024

USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28.

USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28.

Journal: Oncogene
Published: May 30, 2024

PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability.

PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 24, 2024

KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2.

KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2.

Journal: Acta pharmaceutica Sinica. B
Published: January 13, 2024

The Uridylyl Transferase TUT7-Mediated Accumulation of Exosomal miR-1246 Reprograms TAMs to Support CRC Progression.

The Uridylyl Transferase TUT7-Mediated Accumulation of Exosomal miR-1246 Reprograms TAMs to Support CRC Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 25, 2023

Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA.

Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac4C acetylation of KIF23 mRNA.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 27, 2022

UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3.

UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3.

Journal: Oncogene
Published: July 19, 2022

CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.

CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway.

Journal: Cell death & disease
Published: April 13, 2022
Showing 1-12 of 17

Last Updated: 09/26/2026